Syndax Pharmaceuticals Inc - Has Sufficient Cash Runway to Fund Its Research, Clinical Development and Commercial Operations Through 2026
Syndax Pharmicals Inc-在2026年之前有足夠的現金流爲其研究、臨床開發和商業運營提供資金
Syndax Pharmaceuticals Inc - Has Sufficient Cash Runway to Fund Its Research, Clinical Development and Commercial Operations Through 2026
Syndax Pharmicals Inc-在2026年之前有足夠的現金流爲其研究、臨床開發和商業運營提供資金
使用瀏覽器的分享功能,分享給你的好友吧